Over the past decade, creatine has become a popular dietary supplement among professional and recreational athletes because of its reported beneficial effects on exercise performance.1 With worldwide annual consumption estimated to be approximately 2.5 ×106 kg, it can currently be classed as one of the world's best-selling dietary supplements.1 An increase in creatine intake will suppress endogenous production of creatine.2,3 Under normal conditions, creatine synthesis in the liver accounts for nearly 75% of daily homocysteine formation4,5 (Figure 1). An elevated plasma homocysteine concentration is considered an important independent risk factor in the development of cardiovascular disease6; therefore, it is important to establish whether dietary creatine supplementation influences plasma homocysteine concentration. One might predict that an increase in exogenous creatine supply would decrease plasma homocysteine concentration as a consequence of diminished endogenous creatine production (Figure 1), but there are currently no published data available to support this contention. Therefore, the first aim of our study (conducted in the spring of 1998) was to investigate whether prolonged creatine supplementation influenced plasma homocysteine concentration in healthy volunteers.
Schematic representation of interaction between creatine and homocysteine metabolism. An increase in circulating creatine inhibits the activity of the enzyme required for reaction 1 (ie, arginine:glycine amidinotransferase). Consequently, S-adenosylmethionine (SAM) levels rise, which has been proposed to enhance reactions 3 and 4 and to suppress reaction 5. Under normal conditions (ie, normal creatine intake) methionine will interact with guanidinoacetate to form homocysteine (reaction 2, unbroken arrow). The broken arrow (reaction 3) indicates our speculation that this reaction will take place under conditions of high creatine intake, thereby maintaining homocysteine formation. SAH indicates S-adenosylhomocysteine; THF, tetrahydrofolate.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Internal Medicine editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 25
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.